Alvotech (ALVO) Receivables (2020 - 2026)
Alvotech's (ALVO) quarterly Receivables came in at $130.7 million in Q1 2026, up 93.68% YoY from $67.5 million in Q1 2025, and up 5.94% on a QoQ basis from $123.4 million in Q4 2025.
Alvotech (ALVO) Receivables (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has 7 years of Receivables data on file, last reported at $130.7 million in Q1 2026.
- Quarterly Receivables rose 93.68% year-over-year to $130.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $130.7 million (up 93.68% YoY) and the FY2025 annual result came in at $191.4 million, up 19.17% from the prior year.
- Receivables climbed to $130.7 million in Q1 2026, from $123.4 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $130.7 million in Q1 2026 to a low of $16.2 million in Q1 2023.
- A 5-year average of $63.4 million and a median of $63.2 million in 2025 frame the typical range for Receivables.
- Annual changes were most pronounced in 2023 — Receivables slipped 22.35% — and 2024, when it soared 128.65%.
- Tracing ALVO's Receivables over 5 years: stood at $28.2 million in 2022, then jumped by 66.31% to $46.9 million in 2023, then surged by 92.68% to $90.4 million in 2024, then soared by 36.44% to $123.4 million in 2025, then advanced by 5.94% to $130.7 million in 2026.
- The last three Receivables figures came in at $130.7 million (Q1 2026), $123.4 million (Q4 2025), and $58.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.08 Bn |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn | 177.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 130.70 Mn |
| Dec 31, 2025 | 123.37 Mn |
| Sep 30, 2025 | 58.94 Mn |
| Jun 30, 2025 | 78.91 Mn |
| Mar 31, 2025 | 67.48 Mn |
| Dec 31, 2024 | 90.43 Mn |
| Sep 30, 2024 | 68.17 Mn |
| Jun 30, 2024 | 73.32 Mn |
| Mar 31, 2024 | 31.10 Mn |
| Dec 31, 2023 | 46.93 Mn |
| Jun 30, 2023 | 32.07 Mn |
| Mar 31, 2023 | 16.24 Mn |
| Dec 31, 2022 | 28.22 Mn |
| Jun 30, 2022 | 41.30 Mn |
| Dec 31, 2021 | 20.55 Mn |
| Dec 31, 2020 | 35.11 Mn |